EGF-mediated suppression of cell extrusion during mucosal damage attenuates opportunistic fungal invasion

Sebastian Wurster1, Oscar E Ruiz2, Krystin M Samms2

  • 1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Cell Reports
|March 24, 2021
PubMed

Insights

Fungal infections often follow mucosal damage. Enhancing epithelial repair using epigen (epidermal growth factor receptor ligand) can reduce fungal invasion and improve survival in a zebrafish model.

Area of Science:

  • Fungal Pathogenesis
  • Epithelial Biology
  • Zebrafish Models

Background:

  • Opportunistic fungal infections are severe and often fatal, particularly after mucosal damage from trauma or chemotherapy.
  • Epithelial cell interaction with fungal pathogens is critical for invasion, highlighting the need to strengthen epithelial defenses.

Purpose of the Study:

  • To establish a model of fungal infection using inducible epithelial cell loss in larval zebrafish.
  • To investigate the role of epithelial damage and repair in fungal invasion and pathogenesis.
  • To identify molecular mechanisms and therapeutic targets for mitigating fungal infections.

Main Methods:

  • Larval zebrafish model with inducible epithelial cell loss.
  • Assessment of fungal attachment, invasion, and larval lethality.
  • Transcriptional profiling to identify host response genes.
  • Treatment with recombinant human epigen (epidermal growth factor receptor ligand).

Main Results:

  • Epithelial cell loss exposed laminin, increasing fungal attachment, invasion, and lethality.
  • Fungi with defects in adherence or filamentation showed reduced virulence.
  • Mucosal damage significantly upregulated the epidermal growth factor receptor ligand epigen (EPGN).
  • Recombinant human EPGN treatment suppressed epithelial cell extrusion, reduced fungal invasion, and enhanced larval survival.

Conclusions:

  • Augmenting epithelial restorative capacity is a viable strategy to combat pathogenic fungal invasion.
  • Epigen (epidermal growth factor receptor ligand) shows therapeutic potential in mitigating fungal infections by promoting epithelial integrity.
  • The zebrafish model provides a valuable platform for studying host-pathogen interactions and testing interventions for opportunistic fungal diseases.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
812
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
946
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
1.1K